Angiomotin-Like Protein 1 (AMOTL1) Antibody

Background

Angiomotin Like 1 (AMOTL1) is a member of the angiomotin protein family, which is involved in regulating endothelial cell migration, polarity, and vascular stability. AMOTL1 plays a crucial role in maintaining endothelial barrier function and modulating angiogenesis by interacting with tight junction proteins and signaling pathways. It is known to participate in the regulation of the Hippo signaling pathway, where it influences cell proliferation and organ size by interacting with transcriptional regulators such as YAP and TAZ. AMOTL1 is also implicated in tumor progression, as it can modulate cell migration, adhesion, and invasion in cancer cells. Dysregulation of AMOTL1 has been associated with pathological angiogenesis, cancer metastasis, and inflammatory diseases. Its function in maintaining vascular integrity and its interaction with key signaling pathways make AMOTL1 a promising target for therapeutic interventions in vascular disorders and oncology.